Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Palliative Care | 30 | 2023 | 2037 | 1.880 |
Why?
|
| Advance Care Planning | 3 | 2023 | 86 | 1.720 |
Why?
|
| Genital Neoplasms, Female | 3 | 2023 | 735 | 1.080 |
Why?
|
| Advance Directives | 3 | 2023 | 88 | 1.060 |
Why?
|
| Hospital Rapid Response Team | 1 | 2022 | 37 | 0.840 |
Why?
|
| Neoplasms | 29 | 2023 | 15193 | 0.770 |
Why?
|
| Medical Oncology | 4 | 2019 | 1423 | 0.720 |
Why?
|
| Clinical Decision-Making | 2 | 2019 | 524 | 0.660 |
Why?
|
| Professional-Family Relations | 2 | 2017 | 134 | 0.650 |
Why?
|
| Terminal Care | 6 | 2018 | 447 | 0.590 |
Why?
|
| Hospices | 2 | 2016 | 51 | 0.570 |
Why?
|
| Pain | 10 | 2022 | 1658 | 0.570 |
Why?
|
| Cancer Care Facilities | 7 | 2021 | 884 | 0.550 |
Why?
|
| Hospice Care | 1 | 2016 | 156 | 0.490 |
Why?
|
| Outpatients | 4 | 2023 | 462 | 0.460 |
Why?
|
| Documentation | 2 | 2019 | 207 | 0.440 |
Why?
|
| Resuscitation Orders | 3 | 2010 | 68 | 0.420 |
Why?
|
| Communication | 6 | 2019 | 876 | 0.410 |
Why?
|
| Oxycodone | 3 | 2000 | 29 | 0.400 |
Why?
|
| Critical Care | 1 | 2017 | 770 | 0.390 |
Why?
|
| Fever | 2 | 2006 | 497 | 0.390 |
Why?
|
| National Cancer Institute (U.S.) | 3 | 2021 | 211 | 0.380 |
Why?
|
| Caregivers | 1 | 2015 | 677 | 0.350 |
Why?
|
| Patient Participation | 3 | 2023 | 446 | 0.340 |
Why?
|
| Decision Making | 5 | 2022 | 1287 | 0.330 |
Why?
|
| Morphine | 2 | 2000 | 308 | 0.310 |
Why?
|
| Electronic Health Records | 3 | 2020 | 929 | 0.310 |
Why?
|
| Patient Care Planning | 3 | 2022 | 297 | 0.290 |
Why?
|
| Hot Flashes | 1 | 2006 | 37 | 0.280 |
Why?
|
| Referral and Consultation | 3 | 2009 | 899 | 0.280 |
Why?
|
| Analgesics, Opioid | 5 | 2017 | 1371 | 0.260 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2004 | 15 | 0.250 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2010 | 164 | 0.240 |
Why?
|
| Humans | 48 | 2023 | 261506 | 0.230 |
Why?
|
| Sweating | 1 | 2002 | 10 | 0.220 |
Why?
|
| Program Development | 2 | 2000 | 261 | 0.210 |
Why?
|
| Data Collection | 1 | 2004 | 620 | 0.200 |
Why?
|
| Pelvic Neoplasms | 1 | 2003 | 189 | 0.200 |
Why?
|
| Abdominal Neoplasms | 1 | 2003 | 231 | 0.200 |
Why?
|
| Intestinal Obstruction | 1 | 2003 | 202 | 0.190 |
Why?
|
| Pediatrics | 2 | 2012 | 1141 | 0.190 |
Why?
|
| Delirium | 3 | 2017 | 207 | 0.190 |
Why?
|
| Emotions | 3 | 2022 | 562 | 0.170 |
Why?
|
| Goals | 2 | 2016 | 185 | 0.170 |
Why?
|
| Community Health Services | 1 | 2000 | 126 | 0.170 |
Why?
|
| Female | 26 | 2023 | 141928 | 0.160 |
Why?
|
| Patient Care Team | 3 | 2017 | 795 | 0.160 |
Why?
|
| Physician-Patient Relations | 4 | 2018 | 792 | 0.160 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2003 | 600 | 0.160 |
Why?
|
| Lorazepam | 1 | 2017 | 40 | 0.150 |
Why?
|
| Haloperidol | 1 | 2017 | 64 | 0.150 |
Why?
|
| Anti-Anxiety Agents | 1 | 2017 | 90 | 0.150 |
Why?
|
| Pain Management | 2 | 2017 | 668 | 0.150 |
Why?
|
| Telemedicine | 1 | 2023 | 471 | 0.140 |
Why?
|
| Fellowships and Scholarships | 1 | 2000 | 390 | 0.140 |
Why?
|
| Pandemics | 2 | 2023 | 1559 | 0.140 |
Why?
|
| Social Support | 2 | 2017 | 560 | 0.140 |
Why?
|
| Pain Measurement | 5 | 2010 | 953 | 0.140 |
Why?
|
| Male | 21 | 2022 | 123000 | 0.140 |
Why?
|
| Qualitative Research | 1 | 2017 | 556 | 0.130 |
Why?
|
| Retrospective Studies | 7 | 2022 | 37905 | 0.130 |
Why?
|
| Mind-Body Therapies | 1 | 2014 | 29 | 0.130 |
Why?
|
| Quality of Life | 4 | 2023 | 4532 | 0.120 |
Why?
|
| Leadership | 1 | 2017 | 254 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2000 | 671 | 0.120 |
Why?
|
| Ohio | 3 | 2004 | 113 | 0.120 |
Why?
|
| Terminally Ill | 2 | 2008 | 91 | 0.120 |
Why?
|
| Spirituality | 1 | 2014 | 129 | 0.120 |
Why?
|
| Bereavement | 2 | 2012 | 27 | 0.110 |
Why?
|
| Adult | 16 | 2022 | 77950 | 0.110 |
Why?
|
| Antipsychotic Agents | 1 | 2017 | 414 | 0.110 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 460 | 0.110 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2006 | 126 | 0.110 |
Why?
|
| Cancer Pain | 1 | 2017 | 312 | 0.110 |
Why?
|
| Patient Preference | 1 | 2014 | 218 | 0.110 |
Why?
|
| Severity of Illness Index | 4 | 2015 | 4320 | 0.100 |
Why?
|
| Interprofessional Relations | 2 | 2004 | 213 | 0.090 |
Why?
|
| Health Personnel | 1 | 2016 | 625 | 0.090 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 764 | 0.090 |
Why?
|
| Aged | 14 | 2022 | 70117 | 0.090 |
Why?
|
| Adolescent | 7 | 2022 | 31252 | 0.090 |
Why?
|
| Acute Disease | 1 | 2015 | 2422 | 0.090 |
Why?
|
| Middle Aged | 17 | 2017 | 86204 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 1995 | 915 | 0.090 |
Why?
|
| Defecation | 1 | 2009 | 58 | 0.080 |
Why?
|
| Injections, Intravenous | 2 | 2000 | 573 | 0.080 |
Why?
|
| Naltrexone | 1 | 2009 | 87 | 0.080 |
Why?
|
| Databases as Topic | 1 | 2008 | 133 | 0.080 |
Why?
|
| Medical Audit | 1 | 2009 | 188 | 0.080 |
Why?
|
| Conscious Sedation | 1 | 2008 | 104 | 0.080 |
Why?
|
| Narcotic Antagonists | 1 | 2009 | 129 | 0.080 |
Why?
|
| Constipation | 1 | 2009 | 177 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2008 | 218 | 0.070 |
Why?
|
| United States | 5 | 2021 | 15433 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 2594 | 0.070 |
Why?
|
| Ambulatory Care | 2 | 2023 | 554 | 0.070 |
Why?
|
| Progestins | 1 | 2006 | 87 | 0.070 |
Why?
|
| Body Temperature Regulation | 1 | 2006 | 38 | 0.070 |
Why?
|
| Child | 4 | 2022 | 29154 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2000 | 1544 | 0.070 |
Why?
|
| Young Adult | 6 | 2022 | 21445 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2011 | 1171 | 0.070 |
Why?
|
| Analgesics | 3 | 2010 | 390 | 0.060 |
Why?
|
| Complementary Therapies | 1 | 2006 | 126 | 0.060 |
Why?
|
| Parents | 1 | 2012 | 998 | 0.060 |
Why?
|
| Forms and Records Control | 1 | 2004 | 27 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 4938 | 0.060 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2008 | 318 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2006 | 205 | 0.060 |
Why?
|
| Aged, 80 and over | 8 | 2017 | 29902 | 0.060 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 332 | 0.060 |
Why?
|
| Computers | 1 | 2023 | 141 | 0.060 |
Why?
|
| Thioridazine | 1 | 2002 | 4 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 2 | 2015 | 589 | 0.050 |
Why?
|
| Patient Admission | 1 | 2004 | 220 | 0.050 |
Why?
|
| Cimetidine | 1 | 2002 | 28 | 0.050 |
Why?
|
| Baths | 1 | 2002 | 16 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2004 | 313 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 461 | 0.050 |
Why?
|
| Histamine H2 Antagonists | 1 | 2002 | 50 | 0.050 |
Why?
|
| Cryotherapy | 1 | 2002 | 67 | 0.050 |
Why?
|
| Continuity of Patient Care | 1 | 2004 | 225 | 0.050 |
Why?
|
| Causality | 1 | 2002 | 178 | 0.050 |
Why?
|
| Somatostatin | 1 | 2002 | 114 | 0.050 |
Why?
|
| Body Temperature | 1 | 2002 | 158 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2002 | 4744 | 0.050 |
Why?
|
| Dyspnea | 1 | 2004 | 416 | 0.050 |
Why?
|
| Symptom Assessment | 1 | 2023 | 267 | 0.050 |
Why?
|
| Prospective Studies | 4 | 2015 | 12873 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 289 | 0.050 |
Why?
|
| Eligibility Determination | 1 | 2000 | 77 | 0.050 |
Why?
|
| Double-Blind Method | 3 | 2017 | 2588 | 0.050 |
Why?
|
| Texas | 4 | 2015 | 6311 | 0.050 |
Why?
|
| Models, Organizational | 1 | 2000 | 76 | 0.040 |
Why?
|
| Autonomic Nerve Block | 1 | 1989 | 12 | 0.040 |
Why?
|
| Endocrine System Diseases | 1 | 2000 | 83 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2004 | 2803 | 0.040 |
Why?
|
| Family Health | 1 | 2000 | 325 | 0.040 |
Why?
|
| World Health Organization | 1 | 2000 | 316 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 2000 | 161 | 0.040 |
Why?
|
| Hematologic Diseases | 1 | 2000 | 242 | 0.040 |
Why?
|
| Fatigue | 1 | 2004 | 1239 | 0.040 |
Why?
|
| Research | 1 | 2000 | 415 | 0.040 |
Why?
|
| Pain, Intractable | 1 | 1989 | 171 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2023 | 799 | 0.040 |
Why?
|
| Physician's Role | 1 | 2000 | 238 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2000 | 246 | 0.040 |
Why?
|
| Ovarian Neoplasms | 2 | 2014 | 4638 | 0.040 |
Why?
|
| Cytokines | 1 | 2006 | 2809 | 0.040 |
Why?
|
| Ethics, Medical | 1 | 2000 | 442 | 0.040 |
Why?
|
| Attitude to Death | 2 | 2012 | 100 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2000 | 500 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 8865 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2000 | 786 | 0.030 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2014 | 153 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2992 | 0.030 |
Why?
|
| Hospital Mortality | 2 | 2012 | 1274 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 5687 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 918 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2009 | 16273 | 0.030 |
Why?
|
| APACHE | 1 | 2012 | 93 | 0.030 |
Why?
|
| Psychotherapy | 1 | 2014 | 247 | 0.030 |
Why?
|
| Home Care Services | 1 | 1993 | 92 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 2315 | 0.030 |
Why?
|
| Focus Groups | 1 | 2012 | 256 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2010 | 573 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2012 | 257 | 0.020 |
Why?
|
| Nomograms | 1 | 2012 | 313 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 866 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1945 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1993 | 583 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2011 | 9180 | 0.020 |
Why?
|
| Forecasting | 1 | 2012 | 694 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 5767 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2009 | 67 | 0.020 |
Why?
|
| Pneumonia | 1 | 2015 | 751 | 0.020 |
Why?
|
| Disease Progression | 1 | 2000 | 6682 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2010 | 430 | 0.020 |
Why?
|
| Hospitalization | 1 | 2017 | 2083 | 0.020 |
Why?
|
| Receptors, Opioid, mu | 1 | 2009 | 86 | 0.020 |
Why?
|
| Nausea | 1 | 2010 | 525 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2012 | 441 | 0.020 |
Why?
|
| Analgesia | 1 | 2009 | 94 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 2014 | 821 | 0.020 |
Why?
|
| Anxiety | 1 | 2014 | 1179 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 1544 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2002 | 13658 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2009 | 32848 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 3441 | 0.020 |
Why?
|
| Depression | 1 | 2014 | 1715 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2004 | 209 | 0.010 |
Why?
|
| Reimbursement Mechanisms | 1 | 2004 | 78 | 0.010 |
Why?
|
| Critical Illness | 1 | 2009 | 714 | 0.010 |
Why?
|
| Medical Records | 1 | 2004 | 415 | 0.010 |
Why?
|
| Medical History Taking | 1 | 2003 | 173 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 15694 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1989 | 5061 | 0.010 |
Why?
|
| Physical Examination | 1 | 2003 | 299 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2010 | 6100 | 0.010 |
Why?
|
| Celiac Plexus | 1 | 1989 | 13 | 0.010 |
Why?
|
| Splanchnic Nerves | 1 | 1989 | 13 | 0.010 |
Why?
|
| Intercostal Nerves | 1 | 1989 | 33 | 0.010 |
Why?
|
| Religion | 1 | 2000 | 91 | 0.010 |
Why?
|
| Bioethics | 1 | 2000 | 70 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2003 | 636 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1998 | 208 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2003 | 2292 | 0.010 |
Why?
|
| Length of Stay | 1 | 2004 | 1900 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 14889 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 21713 | 0.010 |
Why?
|
| Hematocrit | 1 | 1993 | 142 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 2403 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 12926 | 0.010 |
Why?
|
| Risk Factors | 1 | 2003 | 17523 | 0.000 |
Why?
|